Physician
Cardiology
Dr. Koonlawee Nademanee, MD
|
|
Give Review
Koonlawee Nademanee is an expert in the field of Cardiology. He has 2 awards "Super Doctor" and "Fellow (FACC)". Koonlawee Nademanee is also published. He has 101 publications published. The lastest publication: "Long-term antithrombotic treatment for atrial fibrillation.' Koonlawee Nademanee accepts Medicare payments and is registered with Medicare.gov.
Publications
- Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.
- Benefits and risks of catheter ablation in elderly patients with Atrial fibrillation.
- Overlapping Risks of Early Repolarization and Brugada Syndrome.
- Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of Atrial fibrillation.
- Exercise and Vagal Reflex in Long QT Syndrome Type 1.
- Reversibility of tachyCardiomyopathy after successful radiofrequency catheter ablation: intermediate results.
- Biosense mapping for ablation of ventricular tachycardia in Cardiomyopathy.
- The use of nonfluoroscopic catheter-based mapping system to perform radiofrequency ablation in complex ventricular tachycardia after cardiac surgery in congenital hear...
- What is the sudden death syndrome in Southeast Asian males?
- Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy.
- Nonfluoroscopic three-dimensional mapping for arrhythmia ablation: tool or toy?
- Initial clinical experience with a fully automatic in-hospital external cardioverter defibrillator.
- Long-term antithrombotic treatment for Atrial fibrillation.
- A nonfluoroscopic catheter-based mapping technique to ablate focal ventricular tachycardia.
- Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men.
- Sudden unexplained death syndrome in Southeast Asia.
- Clinical significance of a new P wave lead vector for pacemaker follow-up of Atrial functions.
- Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy.
- Successful implantation of transvenous automatic implantable cardioverter defibrillator (AICD): the first case report in Thailand.
- Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyArrhythmias: results of a multicenter trial. The Flecainide Suprave...
- Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in Chronic stable angina.
- Intravascular ultrasonography for the diagnosis of traumatic aortic disruption: a case report.
- Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
- Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory Atrial fibrillation or flutter.
- Amiodarone and post-MI patients.
- Radiofrequency catheter ablation in idiopathic ventricular tachycardia with structurally normal Heart.
- Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained Syncope and positive upright tilt table test results.
- Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after Chronic amiodarone administration.
- Control of refractory life-threatening ventricular tachyArrhythmias by amiodarone.
- Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring Chronic drug therapy.
- Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular Arrhythmias: potent suppression of spontaneously occ...
- Accurate rapid compact analog method for the quantification of frequency and duration of myocardial ischemia by semiautomated analysis of 24-hour Holter ECG recordings.
- More on amiodarone for ventricular tachyArrhythmias.
- Amiodarone kinetics after oral doses.
- Electrophysiologic and hemodynamic effects of slow-channel blocking drugs.
- Amiodarone and ventricular tachycardia.
- Amiodarone in refractory life-threatening ventricular Arrhythmias.
- Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs.
- Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications.
- Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
- Control of sudden recurrent arrhythmic deaths: role of amiodarone.
- Recent trends in the management of life-threatening ventricular Arrhythmias.
- Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations.
- Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy.
- The electrophysiology and pharmacology of verapamil, flecainide, and amiodarone: correlations with clinical effects and antiarrhythmic actions.
- Antiarrhythmic effects of verapamil.
- Calcium antagonists. Clinical use in the treatment of Arrhythmias.
- Beta-adrenergic blockade by nadolol in control of ventricular tachyArrhythmias.
- The clinical results of amiodarone in cardiac Arrhythmias: optimal dosing.
- Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyArrhythmias.
- Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone.
- Atrioventricular block complicating amiodarone-induced hypothyroidism in a patient with pre-excitation and rate-dependent bilateral bundle branch block.
- Mexiletine: double-blind comparison with procainamide in PVC suppression and open-label sequential comparison with amiodarone in life-threatening ventricular Arrhythmias.
- Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil.
- Prevalence and prognostic significance of silent myocardial ischemia in patients with unstable angina.
- Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac Arrhythmias.
- Hemodynamic and electrocardiographic correlates of symptomatic and silent myocardial ischemia: pathophysiologic and therapeutic implications.
- Characteristics and clinical significance of silent myocardial ischemia in unstable angina.
- Hemodynamic and electrophysiologic effects of combined infusion of lidocaine and propafenone in humans.
- Characterization of silent ischemia in patients with unstable angina: prognostic and therapeutic implications.
- Circadian variation in occurrence of transient overt and silent myocardial ischemia in Chronic stable angina and comparison with Prinzmetal angina in men.
- Ketanserin and QTc prolongation.
- Prognostic significance of silent myocardial ischemia in patients with unstable angina.
- Newer concepts in the pathogenesis of myocardial ischaemia. Implications for the evaluation of antianginal therapy.
- Clinical and electrophysiologic effects of amiodarone in patients with Atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
- Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
- Sotalol: a beta blocker with unique antiarrhythmic properties.
- Control of cardiac Arrhythmias by calcium antagonism.
- Severity of silent myocardial ischemia on ambulatory electrocardiographic monitoring in patients with stable angina pectoris: relation to prognostic determinants durin...
- Second-generation calcium antagonists: search for greater selectivity and versatility.
- Abolition of Holter monitor-detected silent myocardial ischemia after percutaneous transluminal Coronary angioplasty.
- Fractionated endocardial electrograms are associated with slow conduction in humans: evidence from pace-mapping.
- Beta-adrenergic blockade in unstable angina pectoris.
- Calcium antagonists and beta blockers in the control of mild to moderate systemic Hypertension, with particular reference to verapamil and propranolol.
- Myocardial ischemia during cocaine withdrawal.
- Programmed electrical stimulation at potential ventricular reentry circuit sites. Comparison of observations in humans with predictions from computer simulations.
- Amiodarone and thyroid function.
- Slow conduction in the infarct scar: relevance to the occurrence, detection, and ablation of ventricular reentry circuits resulting from myocardial infarction.
- The historical development, cellular electrophysiology and pharmacology of amiodarone.
- Control of cardiac Arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations.
- Variability of indexes for myocardial ischemia: a comparison of exercise treadmill test, ambulatory electrocardiographic monitoring and symptoms of myocardial ischemia.
- Oral N-acetylprocainamide compared to quinidine plus digoxin in the chronic suppression of Atrial flutter in humans.
- Resetting of ventricular tachycardia: implications for localizing the area of slow conduction.
- Cardiac electrophysiologic effects of intravenous ketanserin in humans.
- Antihypertensive compounds as antiarrhythmic agents: focus on beta-blocking drugs in ventricular Arrhythmias.
- Arrhythmia control by selective lengthening of cardiac repolarization: role of N-acetylprocainamide, active metabolite of procainamide.
- Use of calcium antagonists for cardiac Arrhythmias.
- Effects of sotalol on ventricular tachycardia and Fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents.
- Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
- The amiodarone--class I agent combination increases refractoriness, conduction, and the number of electrophysiologic studies. But does it increase survival rate?
- Ventricular Arrhythmias in ischemic heart disease.
- Refractory ventricular Fibrillation in the electrophysiology laboratory: a nightmare from which we can awaken.
- Prevalence of myocardial ischemia in cocaine addicts.
- A tale of the spontaneous variability of premature ventricular contractions.
- Treatment of catecholamine-sensitive right ventricular tachycardia by endocardial catheter ablation.
- Identifying sites for catheter ablation of ventricular tachycardia.
- Cardiovascular effects and toxicities of cocaine.
- The amiodarone odyssey.
- Hypothalamic-pituitary function during alcohol exposure and withdrawal and cocaine exposure.
- Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
Schools
Chulalongkom University Faculty of Medicine
Tulane University Touro Infrmry
Touro Infirmary
Vet Affairs Med Center W La
UCLA Wadsworth Va Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomyopathy
- Congestive Heart Failure
- Coronary Artery Disease (CAD)
- View All
Doctors Specialties
- Cardiology
- Clinical Cardiac Electrophysiology
Accepted Insurances
Awards
- Super Doctor
- Fellow (FACC)
Education
-
VA Greater Los Angeles Healthcare System -
Tulane University -
Chulalongkorn University Faculty of Medicine
Hospital
-
White Memorial Medical Center
Drug Facts
| NPI NUMBER | 1699882415 | |
| NPPES Provider LastName | NADEMANEE | |
| NPPES Provider FirstName | KOONLAWEE | |
| NPPES Provider ZIPCode | 900332434 | |
| NPPES Provider State | CA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 895.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699882415 |
| Last Name Of The Provider | NADEMANEE |
| First Name Of The Provider | KOONLAWEE |
| View All |
Similar Doctors
|
|
Dr. David S. Cannom, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noel G. Boyle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James R. Katz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tourage Soleimani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sen Ji, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael B. Jorgensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank Litvack, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert A. Ruelaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yuh-Jer A. Shen, MD |
|
|
Dr. Janet Wei, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walter F. Kerwin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edwin A. Lee, MD |
|
|
Dr. Somjot S. Brar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Niraj S. Doctor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip Levine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suresh P. Rao, MD |